tiprankstipranks
Trending News
More News >
Fennec Pharmaceuticals (TSE:FRX)
:FRX
Canadian Market

Fennec Pharmaceuticals (FRX) Cash flow

Compare
27 Followers

Fennec Pharmaceuticals Cash Flow

TSE:FRX's free cash flow for Q3 2025 was $1.49M. For the 2025 fiscal year, TSE:FRX's free cash flow was decreased by $44.12M and operating cash flow was $1.49M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ 26.98M$ -17.14M$ -18.06M$ -14.22M$ -15.60M
Investing Cash Flow
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow
$ -13.62M$ 6.64M$ 20.73M$ 4.98M$ 32.29M
End Cash Position
$ 26.63M$ 13.27M$ 23.77M$ 21.10M$ 30.34M
Free Cash Flow
$ 26.98M$ -17.14M$ -18.06M$ -14.22M$ -15.60M
Currency in USD

Fennec Pharmaceuticals Cash Flow